WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

WMT

128.64

-1.05%↓

COST

1,009.87

-0.12%↓

PEP

155.48

-0.01%↓

TGT

129.55

+0.47%↑

KR

66.66

-1.02%↓

Search

Afya Ltd (Class A)

Отворен

СекторДефанзивни потребителски стоки

14 0.14

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

13.71

Максимум

14.11

Ключови измерители

By Trading Economics

Приходи

-5M

176M

Продажби

-1.6M

927M

P/E

Средно за сектора

9.588

29.378

Дивидентна доходност

4.14

Марж на печалбата

18.945

Служители

9,395

EBITDA

-120M

277M

Препоръки

By TipRanks

Препоръки

Продай

12-месечна прогноза

+18.11% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

4.14%

4.42%

Следващи печалби

7.05.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

149M

1.4B

Предишно отваряне

13.86

Предишно затваряне

14

Настроения в новините

By Acuity

100%

0%

125 / 131 Класиране в Consumer defensive

Техническа оценка

By Trading Central

Увереност

Bullish Evidence

Afya Ltd (Class A) Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

26.04.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26.04.2026 г., 21:14 ч. UTC

Значими събития в новините

Week Ahead for FX, Bonds: Major Central Bank -2-

24.04.2026 г., 19:19 ч. UTC

Придобивния, сливания и поглъщания

Intertek Group Rejects EQT's Revised Offer

26.04.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26.04.2026 г., 23:44 ч. UTC

Печалби

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26.04.2026 г., 23:44 ч. UTC

Печалби

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26.04.2026 г., 23:36 ч. UTC

Пазарно говорене
Значими събития в новините

Gold Falls Amid Dollar's Strength -- Market Talk

26.04.2026 г., 23:33 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26.04.2026 г., 05:12 ч. UTC

Печалби

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26.04.2026 г., 05:12 ч. UTC

Печалби

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26.04.2026 г., 05:12 ч. UTC

Печалби

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26.04.2026 г., 05:12 ч. UTC

Печалби

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24.04.2026 г., 23:37 ч. UTC

Придобивния, сливания и поглъщания

Scoring the Cook Era -- Barrons.com

24.04.2026 г., 20:51 ч. UTC

Придобивния, сливания и поглъщания

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24.04.2026 г., 20:50 ч. UTC

Пазарно говорене
Значими събития в новините

Financial Services Roundup: Market Talk

24.04.2026 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

24.04.2026 г., 20:39 ч. UTC

Придобивния, сливания и поглъщания

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24.04.2026 г., 20:09 ч. UTC

Печалби

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24.04.2026 г., 19:48 ч. UTC

Пазарно говорене
Значими събития в новините

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24.04.2026 г., 19:25 ч. UTC

Придобивния, сливания и поглъщания

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24.04.2026 г., 19:25 ч. UTC

Придобивния, сливания и поглъщания

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24.04.2026 г., 19:22 ч. UTC

Печалби

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24.04.2026 г., 19:06 ч. UTC

Печалби

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24.04.2026 г., 19:05 ч. UTC

Пазарно говорене

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24.04.2026 г., 18:30 ч. UTC

Придобивния, сливания и поглъщания

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24.04.2026 г., 18:28 ч. UTC

Придобивния, сливания и поглъщания

Intertek Rejects Revised EQT Offer

24.04.2026 г., 18:12 ч. UTC

Пазарно говорене

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24.04.2026 г., 18:06 ч. UTC

Пазарно говорене

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24.04.2026 г., 17:42 ч. UTC

Печалби

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24.04.2026 г., 17:28 ч. UTC

Печалби

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Сравнение с други в отрасъла

Ценова промяна

Afya Ltd (Class A) Прогноза

Ценова цел

By TipRanks

18.11% нагоре

12-месечна прогноза

Среден 16.5 USD  18.11%

Висок 17 USD

Нисък 16 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Afya Ltd (Class A) през последните три месеца.

Консенсусна оценка

By TipRanks

Продай

2 ratings

0

Купи

1

Задържане

1

Продай

Техническа оценка

By Trading Central

18.968 / 19.56Подкрепа & съпротива

Краткосрочен план

Bullish Evidence

Средносрочен план

Bullish Evidence

Дългосрочен план

Strong Bullish Evidence

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Afya Ltd (Class A)

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
help-icon Live chat